Cachet Pharmaceutical Co Ltd (002462) — Strategic Asset Allocation Index
Cachet Pharmaceutical Co Ltd (002462) has a Strategic Asset Allocation Index of 11.4% as of September 2023. Strategic assets (PP&E of CN¥697.71 Million plus long-term investments of CN¥-) total CN¥697.71 Million, measured against net assets of CN¥6.09 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Cachet Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Cachet Pharmaceutical Co Ltd Strategic Asset Allocation Index (2007–2022)
This chart shows how Cachet Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2022. As of September 2023, the index stands at 11.4%, representing strategic assets of CN¥697.71 Million against net assets of CN¥6.09 Billion CNY. See Cachet Pharmaceutical Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Cachet Pharmaceutical Co Ltd (2007–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Cachet Pharmaceutical Co Ltd from 2007 to 2022, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 002462 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 12.4% | CN¥735.93 Million | CN¥735.93 Million | CN¥- | CN¥5.92 Billion | ▼ -2.6 pp |
| 2021 | 15.0% | CN¥850.26 Million | CN¥850.26 Million | CN¥- | CN¥5.66 Billion | ▲ +0.1 pp |
| 2020 | 14.9% | CN¥795.53 Million | CN¥795.53 Million | CN¥- | CN¥5.32 Billion | ▲ +5.4 pp |
| 2019 | 9.5% | CN¥468.05 Million | CN¥468.05 Million | CN¥- | CN¥4.92 Billion | ▲ +0.6 pp |
| 2018 | 8.9% | CN¥332.77 Million | CN¥329.99 Million | CN¥2.78 Million | CN¥3.73 Billion | ▼ -2.0 pp |
| 2017 | 10.9% | CN¥349.85 Million | CN¥343.49 Million | CN¥6.36 Million | CN¥3.20 Billion | ▼ -1.2 pp |
| 2016 | 12.1% | CN¥355.50 Million | CN¥353.01 Million | CN¥2.50 Million | CN¥2.94 Billion | ▼ -5.0 pp |
| 2015 | 17.2% | CN¥377.76 Million | CN¥375.29 Million | CN¥2.46 Million | CN¥2.20 Billion | ▼ -5.4 pp |
| 2014 | 22.6% | CN¥378.34 Million | CN¥378.34 Million | CN¥- | CN¥1.67 Billion | ▼ -4.0 pp |
| 2013 | 26.6% | CN¥346.91 Million | CN¥346.91 Million | CN¥- | CN¥1.30 Billion | ▼ -4.7 pp |
| 2012 | 31.3% | CN¥352.95 Million | CN¥352.95 Million | CN¥- | CN¥1.13 Billion | ▲ +3.7 pp |
| 2011 | 27.6% | CN¥300.82 Million | CN¥300.82 Million | CN¥- | CN¥1.09 Billion | ▲ +2.1 pp |
| 2010 | 25.5% | CN¥261.37 Million | CN¥261.37 Million | CN¥- | CN¥1.02 Billion | ▼ -9.5 pp |
| 2009 | 35.0% | CN¥197.60 Million | CN¥197.60 Million | CN¥- | CN¥563.92 Million | ▲ +13.6 pp |
| 2008 | 21.5% | CN¥101.96 Million | CN¥101.96 Million | CN¥- | CN¥475.03 Million | ▲ +3.7 pp |
| 2007 | 17.7% | CN¥102.32 Million | CN¥102.32 Million | CN¥- | CN¥577.44 Million | — |